PXSTF yields 2000.00% · JNJ yields 2.13%● Live data
📍 PXSTF pulled ahead of the other in Year 1
Combined, PXSTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PXSTF + JNJ for your $10,000?
Phoenix Media Investment (Holdings) Limited, an investment holding company, provides satellite television broadcasting services in the People's Republic of China and internationally. The company operates through five segments: Television Broadcasting, Internet Media, Outdoor Media, Real Estate, and Other Activities. The Television Broadcasting segment engages in broadcasting television programs and commercials; and provision of promotion activities through the operation of Phoenix Chinese and Phoenix InfoNews channels, as well as Phoenix Movies, Phoenix North America Chinese, Phoenix Chinese News and Entertainment, Phoenix Hong Kong, and other channels. The Internet Media segment offers website portal and value-added telecommunication services. The Outdoor Media segment provides outdoor advertising services. The Real Estate segment is involved in the property development and investment activities. The Other Activities segment offers program production and ancillary services, merchandising services, magazine publication and distribution, and other related services. It also provides radio broadcasting; research and development; cultural development; software and games development; trademark and property holding; hotel management; publishing and distributing periodicals; technical and financial consulting; aircraft chartering; exhibition; education technology; programme production; real estate brokerage; mobile value-add; capital market; and management and related services. The company was founded in 1996 and is headquartered in Tai Po, Hong Kong.
Full PXSTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.